InvestorsHub Logo
Followers 65
Posts 2029
Boards Moderated 0
Alias Born 10/31/2017

Re: MI Dendream post# 463572

Saturday, 04/30/2022 9:56:57 PM

Saturday, April 30, 2022 9:56:57 PM

Post# of 700263
Bear, there are people here who know a lot more about patents than I do. I would assume that the combo patent extends the Keytruda patent life when used in combination with Dcvax. I also think that by 2030, Keytruda will rarely be used as mono therapy and it will most always be used with DCVax, especially if the research machine of Merck is driving the label expansion studies for the combo. But honestly, others know better than I.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News